Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation Supported by Third-Party Cord Blood Versus Human Leukocyte Antigen-Matched Sibling Peripheral Blood Stem Cell Transplantation in Hematologic Malignancy Patients

Recent studies have shown that haploidentical hematopoietic stem cell transplantation supported by third-party cord blood (haplo-cord-HSCT) results in rapid hematopoietic recovery, low incidences of graft-versus-host disease (GVHD), and relapse of hematologic malignancies. However, few reports on ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Tingting, Chen, Yan, Liu, Yi, Ma, Xia, Zeng, Cong, Chen, Xu, Wang, Shiyu, Xu, Yajing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331161/
https://www.ncbi.nlm.nih.gov/pubmed/35912178
http://dx.doi.org/10.3389/fonc.2022.922120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331161/
https://www.ncbi.nlm.nih.gov/pubmed/35912178
http://dx.doi.org/10.3389/fonc.2022.922120

Ejemplares similares